People · Operator

Keith Klopcic

Named in public records as an officer, director or promoter · active 2018–2019 · Other

1
Companies
3
Filings
$156.2M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
CANarchy Holding Co LLCOtherSeries D+$156.2M$86.3M2018
Operator network

Keith Klopcic at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Robert Spellman · 3 companies · 1 sharedRobert SpellmanChristopher Akelman · 2 companies · 1 sharedChristopher Akelm…Dale Katechis · 2 companies · 1 sharedDale KatechisFT Chong · 2 companies · 1 sharedFT ChongMarla Sabo · 2 companies · 1 sharedMarla SaboRussell Kazorek · 2 companies · 1 sharedRussell KazorekCharles J.M. Zink · 1 companies · 1 sharedCharles J.M. ZinkCharlie J.M. Zink · 1 companies · 1 sharedCharlie J.M. ZinkChris Akelman · 1 companies · 1 sharedChris AkelmanDan Fireman · 1 companies · 1 sharedDan FiremanJoseph J.M. Redner · 1 companies · 1 sharedJoseph J.M. RednerMark J.M. Rubenstein · 1 companies · 1 sharedMark J.M. Rubenst…Matthew J.M. Fraser · 1 companies · 1 sharedMatthew J.M. Fras…Todd J.M. Whitbeck · 1 companies · 1 sharedTodd J.M. WhitbeckCANarchy Holding Co LLC · $156.2M raisedCANarchy Holding Co L…Keith KlopcicKK
Keith Klopcic Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Keith Klopcic on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Robert Spellman13
Dale Katechis12
Russell Kazorek12
Christopher Akelman12
FT Chong12
Marla Sabo12
Charles J.M. Zink11
Todd J.M. Whitbeck11
Charlie J.M. Zink11
Dan Fireman11
Chris Akelman11
Joseph J.M. Redner11
Mark J.M. Rubenstein11
Matthew J.M. Fraser11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.